# Novartis AG: Form 6-K, filed Oct 25, 2022

- Company: [Novartis AG](/companies/nvs.md) (CIK 1114448)
- Form: 6-K
- Filed: 2022-10-25
- Accepted by EDGAR: Oct 25, 2022, 09:40 ET
- Period: 2022-09-30
- Accession: 0001370368-22-000077
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1114448/000137036822000077/a221025-6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1114448/000137036822000077/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1114448/000137036822000077/a221025-6k.htm

Filed Oct 25, 2022.
Source: SEC EDGAR, the filing index for accession 0001370368-22-000077. Last ingested by Listed: Nov 13, 2026, 16:23 ET. No prices; not investment advice.
